Market Overview:
The global wearable chronic respiratory disease device market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic respiratory diseases, growing awareness about early diagnosis and treatment of chronic respiratory diseases, and technological advancements in wearable devices. The global wearable chronic respiratory disease device market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into monitors, therapeutic devices, and others. The monitors segment is further sub-segmented into spirometers and peak flow meters. The therapeutic devices segment is further sub-segmented into oxygen therapy devices and nebulizers. On the basis of application, the market is divided into hospitals, households, clinics,,and others (including research institutes). Geographically speaking,,the global wearable chronic respiratory disease device market covers North America,,Latin America,,Europe,,,,Asia Pacific,,,,and Middle East & Africa,. Among these regions,.North America holds a major share in this market due to high prevalence rateof chronic respiratory diseases,.advanced healthcare infrastructure,.and rising awareness about early diagnosis among people. Asia Pacificis projectedto grow at a highest CAGR duringthe forecast period owing tobusiness opportunities in countries such as Chinaand India.
Product Definition:
A wearable chronic respiratory disease device is a small, battery-operated device that helps people with chronic respiratory diseases breathe easier. It fits over the nose and mouth like a mask and delivers air from an external source to the lungs. The wearable chronic respiratory disease device is important because it helps people with chronic respiratory diseases breathe easier and reduces the number of hospital visits.
Monitor:
The global monitor, it's usage and growth factor in wearable chronic respiratory disease device market size was valued at USD 6.1 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Therapeutic:
Therapeutic is a wireless and portable respiratory therapy device that helps in improving lung function, reducing the frequency of acute respiratory symptoms, such as cough and sputum production. It also provides an alternative to invasive procedures for patients who are unresponsive or have contraindications for invasive procedures.
Application Insights:
The chronic respiratory diseases (CRCRD) clinic application segment dominated the global wearable chronic respiratory disease device market in 2017. The CRCRD clinic application segment is expected to witness a CAGR of XX% over the forecast period owing to an increase in patients suffering from asthma and other lung diseases, which has resulted in an increased demand for these devices at clinics and hospitals.
In addition, this segment is also anticipated to dominate the household sector owing to rising awareness about early detection of such disorders among both individuals as well as families across all age groups especially pertaining to children with wheezing or breathless coughs or chest tightness. Furthermore, increasing usage of wearable devices by individuals with mild symptoms may result in a potential growth opportunity for market players during the forecast period. However, high initial investment coupled with limited distribution channels are some challenges faced by industry participants that may hinder its growth during the study period thereby restraining overall industry expansion over projected timelines.
Regional Analysis:
North America dominated the global wearable chronic respiratory disease device market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors responsible for its large share. In addition, increasing R&D investments by major players is one of the key trends expected to drive growth during the forecast period.
Asia Pacific is anticipated to be the fastest-growing region during the forecast period owing to rising geriatric population and prevalence of chronic respiratory diseases such as COPD and asthma among others in this region. Moreover, improving healthcare facilities due to growing economy will also boost regional growth over next eight years (from 2018 to 2030). However, low awareness levels about these devices may hinder their usage at times; thus restraining overall market growth from reaching its full potential extent.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This will lead to an increase in the demand for wearable chronic respiratory disease devices, as they are the most effective way to manage these conditions.
- Technological advancements: The wearable chronic respiratory disease device market is constantly evolving with new technological advancements being made every day. This will help improve the efficacy and usability of these devices, thus driving their growth.
- Growing awareness about chronic respiratory diseases: There is a growing awareness among people about the various types of chronic respiratory diseases and their symptoms. This will lead to an increase in the demand for wearable chronic respiratory disease devices, as they are one of the most effective ways to manage these conditions .
Scope Of The Report
Report Attributes
Report Details
Report Title
Wearable Chronic Respiratory Disease Device Market Research Report
By Type
Monitor, Therapeutic, Others
By Application
Hospital, Household, Clinic, Others
By Companies
Philips Respironics, ResMed, GE Healthcare, Smith's Medical, Teleflex, Drager Medical, Hamilton Medical, Briggs Healthcare, Philips Respironics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Wearable Chronic Respiratory Disease Device Market Report Segments:
The global Wearable Chronic Respiratory Disease Device market is segmented on the basis of:
Types
Monitor, Therapeutic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Household, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Philips Respironics
- ResMed
- GE Healthcare
- Smith's Medical
- Teleflex
- Drager Medical
- Hamilton Medical
- Briggs Healthcare
- Philips Respironics
Highlights of The Wearable Chronic Respiratory Disease Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Monitor
- Therapeutic
- Others
- By Application:
- Hospital
- Household
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wearable Chronic Respiratory Disease Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A wearable chronic respiratory device (WCDRD) is a medical device that is worn on the body to help improve breathing. WCDRDs can be used to treat a variety of conditions, including obstructive sleep apnea, asthma, and chronic bronchitis.
Some of the major players in the wearable chronic respiratory disease device market are Philips Respironics, ResMed, GE Healthcare, Smith's Medical, Teleflex, Drager Medical, Hamilton Medical, Briggs Healthcare, Philips Respironics.
The wearable chronic respiratory disease device market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wearable Chronic Respiratory Disease Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wearable Chronic Respiratory Disease Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wearable Chronic Respiratory Disease Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wearable Chronic Respiratory Disease Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wearable Chronic Respiratory Disease Device Market Size & Forecast, 2020-2028
4.5.1 Wearable Chronic Respiratory Disease Device Market Size and Y-o-Y Growth
4.5.2 Wearable Chronic Respiratory Disease Device Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Monitor
5.2.2 Therapeutic
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Household
6.2.3 Clinic
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wearable Chronic Respiratory Disease Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wearable Chronic Respiratory Disease Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Monitor
9.6.2 Therapeutic
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Household
9.10.3 Clinic
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Monitor
10.6.2 Therapeutic
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Household
10.10.3 Clinic
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Monitor
11.6.2 Therapeutic
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Household
11.10.3 Clinic
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Monitor
12.6.2 Therapeutic
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Household
12.10.3 Clinic
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Monitor
13.6.2 Therapeutic
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Household
13.10.3 Clinic
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wearable Chronic Respiratory Disease Device Market: Competitive Dashboard
14.2 Global Wearable Chronic Respiratory Disease Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Philips Respironics
14.3.2 ResMed
14.3.3 GE Healthcare
14.3.4 Smith's Medical
14.3.5 Teleflex
14.3.6 Drager Medical
14.3.7 Hamilton Medical
14.3.8 Briggs Healthcare
14.3.9 Philips Respironics
